After demonstrating a reduction in Tregs in the spleen and the amount of the EGFP (subrogate for FoxP3), following CH exposure, we aimed to determine whether Tregs show changes in suppressive markers at the protein level, following CH. The gene discussed is FOXP3; the disease is cyclic hematopoiesis.